等待开盘 10-31 09:30:00 美东时间
-32.030
-6.65%
 华盛通
华盛通Alnylam stock fell after a strong Q3 with $2.90 EPS and $1.25 billion revenue, a subpoena disclosure, and raised 2025 sales guidance to $3.6 billion–$3.8 billion.
今天 02:39
华盛资讯10月30日讯,ALNYLAM PHARMACEUTICALS, INC.公司今日公布2025财年Q3业绩,公司Q3营收12.49亿美元,同比增长149.3%,股权持有人应占溢利2.51亿美元,扭亏为盈。
10-30 20:32
Alnylam Pharmaceuticals (NASDAQ:ALNY) raises FY2025 sales outlook from $3.300 billion-$3.550 billion to $3.600 billion-$3.800 billion vs $3.526 billion estimate.
10-30 20:25
华盛资讯10月30日讯,ALNYLAM PHARMACEUTICALS, INC.公司今日公布2025财年Q3业绩,公司Q3营收4.57亿美元,同比增长26.6%,股权持有人应占亏损1.92亿美元,同比亏损缩窄34.0%。
10-30 20:20
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
Alnylam Pharmaceuticals (NASDAQ:ALNY) is gearing up to announce its quarterly e...
10-29 22:04
据sphericalinsights预测,2023年全球核苷酸市场(包含寡核苷酸及单体)销售额为7.3亿美元。中国是全球核苷酸最大的生产市场,其中大部分都对外出...
10-29 11:04
“鸽派”降息25基点预定!华尔街押宝明年利率降低至3%以下,美股这八大降息交易方向值得关注,黄金大回撤后还能上车吗?一文带你看懂>>
10-28 10:20
BridgeBio Pharma (NASDAQ:BBIO) shares rose after it announced positive results from its late-stage study of BBP-418 on patients with limb-girdle muscular dystrophy type 2I/R9. The study successfully m...
10-28 01:09